• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虎杖苷联合山楂黄酮通过重塑肠道微生物群和糖脂代谢减轻高脂饮食诱导的动脉粥样硬化。

Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism.

作者信息

Li Dan, Li Yujuan, Yang Shengjie, Zhang Xiaonan, Cao Yu, Zhao Ran, Zhao Yixi, Jin Xiao, Lu Jing, Wang Xinyue, Wang Qiutao, Liu Longtao, Wu Min

机构信息

Guang'an Men Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

The Dongfang Hospital of Beijing University of Chinese Medicine, Beijing, China.

出版信息

Front Pharmacol. 2025 Mar 3;16:1515485. doi: 10.3389/fphar.2025.1515485. eCollection 2025.

DOI:10.3389/fphar.2025.1515485
PMID:40098615
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11911193/
Abstract

BACKGROUND

Atherosclerosis is a widely studied pathophysiological foundation of cardiovascular diseases. Inflammation and dyslipidemia are risk factors that promote the formation of atherosclerotic plaques. The gut microbiota and their metabolites are considered independent risk factors for atherosclerosis. Polydatin combined with hawthorn flavonoids, as the extracts of . and , have shown excellent cardiovascular protective effects. However, the underlying mechanism requires further investigation. Our study aimed to explore the anti-atherosclerotic mechanism through gut microbiota and their metabolites.

METHODS

ApoE mice were fed either a normal-chow diet or a high-fat diet. The polydatin combined with hawthorn flavonoids group received varied doses of polydatin and hawthorn flavonoids: a high dose (polydatin 200 mg/kg daily; hawthorn flavonoids 100 mg/kg daily), a medium dose (polydatin 100 mg/kg daily; hawthorn flavonoids 50 mg/kg daily), and a low dose (polydatin 50 mg/kg daily; hawthorn flavonoids 25 mg/kg daily). The control and model groups were administered distilled water (0.2 mL daily). The experiment lasted for 24 weeks.

RESULTS

Polydatin combined with hawthorn flavonoids administration significantly reduced lipid and inflammatory cytokine levels, meanwhile, the atherosclerotic lesions in a high-fat diet-induced ApoE mice were significantly decreased. Additionally, polydatin combined with hawthorn flavonoids also inhibited the enhancement of trimethylamine N-oxide (TMAO), trimethylamine (TMA) levels of HFD-induced ApoE mice by regulating the expression of hepatic flavin-containing enzyme monooxygenase 3 (FMO3). 16S rRNA sequencing results demonstrated that high-dose polydatin combined with hawthorn flavonoids treatment increased the abundance of , and , and decreased the abundance of . was enriched in the medium-dose polydatin combined with hawthorn flavonoids and simvastatin groups, and was mainly increased in the simvastatin and the low-dose polydatin combined with hawthorn flavonoids groups. According to the metagenetic results, functional annotations also suggested that the biological processes of each group mainly focused on metabolism-related processes. Specifically, polydatin combined with hawthorn flavonoids may regulate the abundance of TMA-producing bacteria (Coriobacteriaceae, , , and ) and related enzymes in glycolipid metabolic pathways to exert an important effect on the prevention of atherosclerosis.

CONCLUSION

Our results suggested that polydatin combined with hawthorn flavonoids could regulate the glucolipid metabolism-related pathway, attenuate inflammatory cytokine levels, and reduce atherosclerotic plaques by remodeling gut microbiota.

摘要

背景

动脉粥样硬化是心血管疾病广泛研究的病理生理基础。炎症和血脂异常是促进动脉粥样硬化斑块形成的危险因素。肠道微生物群及其代谢产物被认为是动脉粥样硬化的独立危险因素。虎杖苷与山楂黄酮作为[具体植物名称1]和[具体植物名称2]的提取物,已显示出优异的心血管保护作用。然而,其潜在机制需要进一步研究。我们的研究旨在通过肠道微生物群及其代谢产物探索抗动脉粥样硬化机制。

方法

给载脂蛋白E(ApoE)小鼠喂食正常饲料或高脂饮食。虎杖苷与山楂黄酮组给予不同剂量的虎杖苷和山楂黄酮:高剂量(虎杖苷每日200mg/kg;山楂黄酮每日100mg/kg)、中剂量(虎杖苷每日100mg/kg;山楂黄酮每日50mg/kg)和低剂量(虎杖苷每日50mg/kg;山楂黄酮每日25mg/kg)。对照组和模型组给予蒸馏水(每日0.2mL)。实验持续24周。

结果

给予虎杖苷与山楂黄酮显著降低脂质和炎性细胞因子水平,同时,高脂饮食诱导的ApoE小鼠的动脉粥样硬化病变显著减少。此外,虎杖苷与山楂黄酮还通过调节肝脏含黄素单加氧酶3(FMO3)的表达,抑制高脂饮食诱导的ApoE小鼠三甲胺N-氧化物(TMAO)、三甲胺(TMA)水平的升高。16S rRNA测序结果表明,高剂量虎杖苷与山楂黄酮治疗增加了[具体菌属1]、[具体菌属2]和[具体菌属3]的丰度,并降低了[具体菌属4]的丰度。[具体菌属5]在中剂量虎杖苷与山楂黄酮及辛伐他汀组中富集,[具体菌属6]主要在辛伐他汀组和低剂量虎杖苷与山楂黄酮组中增加。根据宏基因组结果,功能注释还表明每组的生物学过程主要集中在代谢相关过程。具体而言,虎杖苷与山楂黄酮可能调节产生TMA的细菌(放线菌科、[具体菌属7]、[具体菌属8]和[具体菌属9])的丰度以及糖脂代谢途径中的相关酶,从而对预防动脉粥样硬化发挥重要作用。

结论

我们的结果表明,虎杖苷与山楂黄酮可通过重塑肠道微生物群调节糖脂代谢相关途径,减轻炎性细胞因子水平,并减少动脉粥样硬化斑块。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/68fbaf143a8c/fphar-16-1515485-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/b16504e0ef44/fphar-16-1515485-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/f5ba6655f0e9/fphar-16-1515485-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/184ab30bd38c/fphar-16-1515485-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/bbed8e29c1b8/fphar-16-1515485-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/06903ccf38ec/fphar-16-1515485-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/73580c5122c3/fphar-16-1515485-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/d5869467be30/fphar-16-1515485-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/8aa356a12b28/fphar-16-1515485-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/8be8d9ffb2bd/fphar-16-1515485-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/3f8d79a960a4/fphar-16-1515485-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/68fbaf143a8c/fphar-16-1515485-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/b16504e0ef44/fphar-16-1515485-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/f5ba6655f0e9/fphar-16-1515485-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/184ab30bd38c/fphar-16-1515485-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/bbed8e29c1b8/fphar-16-1515485-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/06903ccf38ec/fphar-16-1515485-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/73580c5122c3/fphar-16-1515485-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/d5869467be30/fphar-16-1515485-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/8aa356a12b28/fphar-16-1515485-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/8be8d9ffb2bd/fphar-16-1515485-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/3f8d79a960a4/fphar-16-1515485-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84fd/11911193/68fbaf143a8c/fphar-16-1515485-g011.jpg

相似文献

1
Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism.虎杖苷联合山楂黄酮通过重塑肠道微生物群和糖脂代谢减轻高脂饮食诱导的动脉粥样硬化。
Front Pharmacol. 2025 Mar 3;16:1515485. doi: 10.3389/fphar.2025.1515485. eCollection 2025.
2
Hawthorn (Crataegus pinnatifida Bunge) leave flavonoids attenuate atherosclerosis development in apoE knock-out mice.山楂(山里红)叶黄酮可减轻载脂蛋白E基因敲除小鼠的动脉粥样硬化发展。
J Ethnopharmacol. 2017 Feb 23;198:479-488. doi: 10.1016/j.jep.2017.01.040. Epub 2017 Jan 21.
3
Edgeworthia gardneri (Wall.) Meisn protects against HFD-induced murine atherosclerosis through improving gut microbiota-mediated intestinal barrier integrity.结香(Edgeworthia gardneri (Wall.) Meisn)通过改善肠道微生物群介导的肠道屏障完整性来预防高脂饮食诱导的小鼠动脉粥样硬化。
Atherosclerosis. 2025 Apr;403:119132. doi: 10.1016/j.atherosclerosis.2025.119132. Epub 2025 Feb 21.
4
Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.山楂叶黄酮通过抑制小鼠巨噬细胞中sPLA2-ⅡA信号通路的SCAP-SREBP2-LDLR途径减轻动脉粥样硬化的恶化。
J Ethnopharmacol. 2024 Jun 12;327:118006. doi: 10.1016/j.jep.2024.118006. Epub 2024 Mar 3.
5
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice.黄连素对高脂饮食喂养的ApoE-/-小鼠动脉粥样硬化及肠道菌群调节的影响及其相关性
Front Pharmacol. 2020 Mar 13;11:223. doi: 10.3389/fphar.2020.00223. eCollection 2020.
6
Hawthorn Extract Alleviates Atherosclerosis through Regulating Inflammation and Apoptosis Related Factors: An Experimental Study.山楂提取物通过调节炎症和凋亡相关因子减轻动脉粥样硬化:一项实验研究。
Chin J Integr Med. 2019 Feb;25(2):108-115. doi: 10.1007/s11655-018-3020-4. Epub 2018 Dec 5.
7
Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats.山楂果实水提物对实验性大鼠动脉粥样硬化的影响。
J Ethnopharmacol. 2013 Jul 9;148(2):563-9. doi: 10.1016/j.jep.2013.04.053. Epub 2013 May 16.
8
Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3.PSRC1 缺乏通过操纵肠道微生物群和黄素单加氧酶 3 增加 TMAO 生成来加速动脉粥样硬化。
Gut Microbes. 2022 Jan-Dec;14(1):2077602. doi: 10.1080/19490976.2022.2077602.
9
Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.虎杖苷通过激活自噬和抑制 NLRP3 炎性体介导的细胞焦亡来防治动脉粥样硬化。
J Ethnopharmacol. 2023 Jun 12;309:116304. doi: 10.1016/j.jep.2023.116304. Epub 2023 Mar 2.
10
Polyphenols from hickory nut reduce the occurrence of atherosclerosis in mice by improving intestinal microbiota and inhibiting trimethylamine N-oxide production.山核桃中的多酚通过改善肠道微生物群和抑制氧化三甲胺的产生来减少小鼠动脉粥样硬化的发生。
Phytomedicine. 2024 Jun;128:155349. doi: 10.1016/j.phymed.2024.155349. Epub 2024 Jan 9.

引用本文的文献

1
Combination of Polydatin and Hawthorn Leave Flavonoids Ameliorate Atherosclerotic Plaque Vulnerability in ApoE Mice by Regulating Ferroptosis via the Nrf2/HO-1/GPX4 Axis.虎杖苷与山楂叶黄酮联合通过Nrf2/HO-1/GPX4轴调控铁死亡改善ApoE小鼠动脉粥样硬化斑块易损性
J Inflamm Res. 2025 Sep 2;18:12105-12121. doi: 10.2147/JIR.S530995. eCollection 2025.

本文引用的文献

1
A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis.一种新型小分子 PCSK9 抑制剂 E28362 可改善血脂异常和动脉粥样硬化。
Acta Pharmacol Sin. 2024 Oct;45(10):2119-2133. doi: 10.1038/s41401-024-01305-9. Epub 2024 May 29.
2
Bile acids metabolism in the gut-liver axis mediates liver injury during lactation.肠-肝轴中的胆汁酸代谢在哺乳期介导肝损伤。
Life Sci. 2024 Feb 1;338:122380. doi: 10.1016/j.lfs.2023.122380. Epub 2023 Dec 22.
3
Dyslipidemia Update.血脂异常更新。
Nurs Clin North Am. 2023 Sep;58(3):295-308. doi: 10.1016/j.cnur.2023.05.002. Epub 2023 Jun 15.
4
Inflammation Beats Cholesterol: A Comment on the Unequivocal Driver of Cardiovascular Disease Risk.炎症战胜胆固醇:关于心血管疾病风险明确驱动因素的评论
J Clin Med. 2023 Mar 27;12(7):2519. doi: 10.3390/jcm12072519.
5
Impavido attenuates inflammation, reduces atherosclerosis, and alters gut microbiota in hyperlipidemic mice.无畏素可减轻高脂血症小鼠的炎症反应,减少动脉粥样硬化,并改变肠道微生物群。
iScience. 2023 Mar 20;26(4):106453. doi: 10.1016/j.isci.2023.106453. eCollection 2023 Apr 21.
6
The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia.细胞色素P450 1A1/2(CYP1A1/2)在胆固醇酯积累中的作用为高胆固醇血症的治疗提供了新的视角。
Acta Pharm Sin B. 2023 Feb;13(2):648-661. doi: 10.1016/j.apsb.2022.08.005. Epub 2022 Aug 13.
7
Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.虎杖苷通过激活自噬和抑制 NLRP3 炎性体介导的细胞焦亡来防治动脉粥样硬化。
J Ethnopharmacol. 2023 Jun 12;309:116304. doi: 10.1016/j.jep.2023.116304. Epub 2023 Mar 2.
8
The Role of Macrophages in the Pathogenesis of Atherosclerosis.巨噬细胞在动脉粥样硬化发病机制中的作用。
Cells. 2023 Feb 5;12(4):522. doi: 10.3390/cells12040522.
9
The Hypolipidemic Effect of Hawthorn Leaf Flavonoids through Modulating Lipid Metabolism and Gut Microbiota in Hyperlipidemic Rats.山楂叶黄酮通过调节高脂血症大鼠脂质代谢和肠道菌群发挥降血脂作用
Evid Based Complement Alternat Med. 2022 Nov 15;2022:3033311. doi: 10.1155/2022/3033311. eCollection 2022.
10
Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways.主动脉和肝脏生成的 TMAO 通过内质网应激/线粒体 ROS/糖酵解途径增强训练免疫以增加炎症。
JCI Insight. 2023 Jan 10;8(1):e158183. doi: 10.1172/jci.insight.158183.